News

Article

KSL Biomedical Acquires Pulse Scientific, Expanding Laboratory and Assay Capabilities

KSL Biomedical announced their expansion into Canada with the acquisition of Pulse Scientific and the incorporation of KSL Biomedical Canada.

KSL Biomedical, developers of novel diagnostic and therapeutic applications, announced their expansion into Canada with the acquisition of Pulse Scientific, a diagnostic products manufacturer and distributor of medical, laboratory, and research products, in a Sept. 27, 2021, press release. The incorporation of KSL Biomedical Canada and the acquisition of Pulse Scientific extended KSL’s international base for product distribution and laboratory sales.

The acquisition positions KSL to distribute medical devices and in-vitro diagnostics in Canada, Europe, and other global markets. In addition, the acquisition allows KSL to add proprietary products and services to its pipeline, including exclusive diagnostics, laboratory products, medical devices, and assays.

Specializing in the manufacturing and distribution of technical microbiology products as well as in-vitro diagnostic (IVD) tests for laboratories and physicians, Pulse Scientific is ISO 13485 certified and licensed by Health Canada. Meanwhile, KSL is a a regulatory agent and contract research organization, and will work to secure Health Canada clearance for manufacturers outside of Canada seeking access to the Canadian market. KSL will also work with Canadian companies seeking regulatory clearances in large markets outside of Canada.

“Our leadership team brings to Canada decades of scientific training and experience in diagnostics and deep relationships with market leaders who can assist in identifying emerging industry opportunities and introducing novel applications to address them. We expect the acquisition to invigorate access to markets for existing Pulse Scientific and KSL Biomedical products, as well as complementary products to be identified by our incoming Canadian business development team,” said Kevin Lawson, president and CEO of KSL Biomedical.

Source: Businesswire, KSL Biomedical

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More
Related Content